Zhejiang Garden Biopharmaceutical Co.,Ltd. (SHE:300401)

China flag China · Delayed Price · Currency is CNY
14.15
-0.25 (-1.74%)
Apr 9, 2026, 2:40 PM CST
Market Cap7.83B -9.1%
Revenue (ttm)1.24B +9.4%
Net Income301.80M +5.9%
EPS0.52 +16.8%
Shares Out543.69M
PE Ratio27.71
Forward PE25.26
Dividend0.11 (0.81%)
Ex-Dividend DateApr 30, 2025
Volume9,825,747
Average Volume16,526,439
Open13.89
Previous Close14.40
Day's Range13.89 - 14.39
52-Week Range11.58 - 19.67
Beta0.60
RSI42.36
Earnings DateApr 18, 2026

About SHE:300401

Zhejiang Garden Biopharmaceutical Co.,Ltd. operates as a food additive and pharmaceutical manufacturing industry in China. The company provides lanolin cholesterol, vitamin A and AD3 particles, vitamin D3, 25-hydroxyvitamin D3, chemical drugs and Chinese patent medicines. It offers cholesterol; feed grade vitamin D3, refined lanolin; food additives compound nutrient fortifier SDS, CO, and MO; cholecalciferol; feed additive - vitamin D3 particles and oil; VD3 resin oil; 25 hydroxyvitamin D3 progen and powder; 25 hydroxyvitamin D3; anhydrous lano... [Read more]

Sector Healthcare
Founded 2000
Employees 1,021
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300401
Full Company Profile

Financial Performance

In 2024, SHE:300401's revenue was 1.24 billion, an increase of 13.58% compared to the previous year's 1.09 billion. Earnings were 309.21 million, an increase of 60.76%.

Financial Statements